Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
Authors
Keywords
-
Journal
DIABETES
Volume 64, Issue 5, Pages 1786-1793
Publisher
American Diabetes Association
Online
2014-12-16
DOI
10.2337/db14-1388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1
- (2014) Liping Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- An update on the pharmacogenomics of metformin: progress, problems and potential
- (2014) Jennifer N Todd et al. PHARMACOGENOMICS
- Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
- (2014) Antonella Napolitano et al. PLoS One
- Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration
- (2013) Mladen V. Tzvetkov et al. BIOCHEMICAL PHARMACOLOGY
- Molecular mechanism of action of metformin: old or new insights?
- (2013) Graham Rena et al. DIABETOLOGIA
- Involvement of Carnitine/Organic Cation Transporter OCTN1/SLC22A4 in Gastrointestinal Absorption of Metformin
- (2013) Noritaka Nakamichi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling
- (2012) Matthias B. Wittwer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients
- (2012) Linda Tarasova et al. Pharmacogenetics and Genomics
- Genetically Polymorphic OCT1: Another Piece in the Puzzle of the Variable Pharmacokinetics and Pharmacodynamics of the Opioidergic Drug Tramadol
- (2011) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Metformin and digestive disorders
- (2011) M. Bouchoucha et al. DIABETES & METABOLISM
- Interactions of Tyrosine Kinase Inhibitors with Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Proteins
- (2011) T. Minematsu et al. MOLECULAR CANCER THERAPEUTICS
- The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
- (2011) Mette M.H. Christensen et al. Pharmacogenetics and Genomics
- Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
- (2011) Anne T. Nies et al. PLoS One
- Genotype Imputation with Thousands of Genomes
- (2011) Bryan Howie et al. G3-Genes Genomes Genetics
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions
- (2010) G Ahlin et al. PHARMACOGENOMICS JOURNAL
- Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron
- (2010) M V Tzvetkov et al. PHARMACOGENOMICS JOURNAL
- Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 Diabetes
- (2010) Hermes Florez et al. POSTGRADUATE MEDICINE
- Current Understanding of the Pharmacogenomics of Metformin
- (2009) O Zolk CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
- (2009) K. Zhou et al. DIABETES
- A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
- (2009) Bryan N. Howie et al. PLoS Genetics
- Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters: Focus on Organic Anion Transporting Polypeptides and Organic Cation Transporter 1
- (2008) I. Bachmakov et al. DIABETES
- Metformin therapy and clinical uses
- (2008) John HB Scarpello et al. Diabetes & Vascular Disease Research
- Metformin and the intestine
- (2008) C. J. Bailey et al. DIABETOLOGIA
- Structural Requirements for Drug Inhibition of the Liver Specific Human Organic Cation Transport Protein 1
- (2008) Gustav Ahlin et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now